Navigation Links
Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
Date:7/23/2009

SAN DIEGO, July 23 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report second quarter 2009 financial results on Thursday, July 30, 2009, after the U.S. financial markets close.

Anadys will hold a conference call and webcast on Thursday, July 30, 2009 at 5:00 p.m. Eastern Daylight Time to discuss its second quarter 2009 financial results and highlights and to provide an update on its development programs. A live webcast of the call will be available online at www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 85411914. The webcast and telephone replay will be available through August 13, 2009.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C. The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines. The Company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C. The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , COPENHAGEN, Nov. 19 Dani...Inbicon cellulosic ethanol plant in Kalundborg, De...one of the world,s first and largest 2nd generatio...Accellerase enzymes are used in the plant,s innova...r, a Division of Danisco, was the first to market ...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 /PRNewswire-FirstCall...oday that it has sent the following letter to its ..., on October 30, 2009, of China Biopharmaceuticals...utical company based in the People,s Republic of C...nterest in Suzhou Eyre Pharmaceutical Co. Ltd., CH...
(Date:11/19/2009)..., , MONTREAL, Nov. 19 /PRNewswire/ - Aegera...he first patient in a randomized Phase 2B study of...-stage development for multiple oncology indicatio...mized Phase 2 Study of the X-Linked Inhibitor of A...ation with High-dose Cytarabine and Idarubicin in ...
(Date:11/19/2009)..., , VIENNA, Austria, November 19 /P...s vaccine program on one product candidate at an u...e candidate AD02 is planned to enter into,Phase II...e company,immediately follows the completion of tw.... The company based its fast decision on the first...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...sides of the planet Uranus, as viewed in this comp...ared wavelengths. Courtesy of Lawrence Sromovsky, ...Capitalizing on the optical capabilities of the K...ented look at the atmosphere of Uranus, providing ...r in the solar system. , ,A pair of images unveile...
...ing slogans or taglines pushing sales are great fo...le and hold them hostage for a second or two. , ,S...re simply confusing, causing them to escape the tr... all the strangely composed slogans promoting vari...ions of dollars. Corporations make extraordinary e...
... like Mick Jagger said: I cant get no satisfaction... to bug you. , ,Old Maslow must have had this in m...strate that getting one set of needs taken care of...s you to start worrying about the next one. This g...s on an iPod. , ,The same applies with the matter ...
Other Biology Technology:UW space scientists use Keck telescope to study wild weather of Uranus 2UW space scientists use Keck telescope to study wild weather of Uranus 3Super advertising slogans, and super costs 2Super advertising slogans, and super costs 3Super advertising slogans, and super costs 4How to solve the salary mystery 2How to solve the salary mystery 3How to solve the salary mystery 4
(Date:11/20/2009)...chers are at work on many scientific and technolog...s recently provided support that totals nearly $4.... investigators under the American Recovery and Rei... been awarded grants for investigation of solar ph...of physics, will enhance the capabilities of NJIT,...
(Date:11/20/2009)...precise measurements of plasma lipoprotein concent...pectroscopy (NMR), researchers led by Daniel Chasm...ical School in Boston, MA, the Framingham Heart St... Stockholm, Sweden and Oxford, England performed g...e among 17,296 women of European ancestry from the...
(Date:11/20/2009)..., DC Nov. 20, 2009) Scientists from the Marine B... of the Naval Research Laboratory (NRL) organized ...ists on an Arctic expedition to initiate methane h...ne the spatial variation of sediment contribution ...oast Guard Cutter Polar Sea as a research platform...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2International expedition investigates climate change, alternative fuels in Arctic 2SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in France 50899 1SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in France 50899 2SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in France 50899 3VerteLoc 26amp 3B 238482 3B Tops 500 Surgical Procedures VGI Announces VerteLX 26amp 3B 238482 3B and Seeks Potential Investors for Growth 12915 1VerteLoc 26amp 3B 238482 3B Tops 500 Surgical Procedures VGI Announces VerteLX 26amp 3B 238482 3B and Seeks Potential Investors for Growth 12915 2Connectyx Technologies Holdings Group Inc Increases Revenues by 45 25 and Reduces Expenses by 20 25 for the Second Quarter of 2009 Versus Second Qua 50893 1Connectyx Technologies Holdings Group Inc Increases Revenues by 45 25 and Reduces Expenses by 20 25 for the Second Quarter of 2009 Versus Second Qua 50893 2Connectyx Technologies Holdings Group Inc Increases Revenues by 45 25 and Reduces Expenses by 20 25 for the Second Quarter of 2009 Versus Second Qua 50893 3
...eeding habits, clams have been silent witnesses to... waters. These clams are silent no more, as Dr. R...d her colleagues have reported in their recent pap...Using stable isotope techniques, Carmichael demons...ater inputs to estuaries and coastal food webs by ...
...ersity of New Jersey, has received a four-year, $1...ation to establish the Institute for Food, Nutriti...gers President Richard L. McCormick announced his ...s Annual Address to the University Community on Se...he new institute would focus on obesity and its as...
...emeinschaft (DFG, German Research Foundation) will...ey will be initially funded for the next four year...Among other things, the new Collaborative Research... by viruses and bacteria, scarring of the liver an...e the optimisation of planning, production and uti...
Other Biology News:Rutgers receives US$10 million to establish Institute for Food, Nutrition and Health 2From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 2From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 3From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 4From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 5From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 6From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 7
Sheep Anti-Mouse GDF-8 Polyclonal Antibodies, from R&D Systems
Rabbit Anti-SOX10 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Normal Human Serum from 3H Biomedical AB
...d USDA Research Registered OLAW Assured AAALAC Acc... AALAS Certified Technicians Documentation GLP P...equest Focus CRP is your one stop shopping point... offer free project consultation, free peptide seq...
Biology Products: